Cargando…
Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy
Purpose. The purpose of this study was to examine the relationship between metabolic and inflammatory markers in patients with diabetic retinopathy (DR). Methods. 208 adult patients with type 2 diabetes participated in this study and were categorized into (1) mild nonproliferative diabetic retinopat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532932/ https://www.ncbi.nlm.nih.gov/pubmed/26295054 http://dx.doi.org/10.1155/2015/191382 |
_version_ | 1782385275108851712 |
---|---|
author | Crosby-Nwaobi, Roxanne Chatziralli, Irini Sergentanis, Theodoros Dew, Tracy Forbes, Angus Sivaprasad, Sobha |
author_facet | Crosby-Nwaobi, Roxanne Chatziralli, Irini Sergentanis, Theodoros Dew, Tracy Forbes, Angus Sivaprasad, Sobha |
author_sort | Crosby-Nwaobi, Roxanne |
collection | PubMed |
description | Purpose. The purpose of this study was to examine the relationship between metabolic and inflammatory markers in patients with diabetic retinopathy (DR). Methods. 208 adult patients with type 2 diabetes participated in this study and were categorized into (1) mild nonproliferative diabetic retinopathy (NPDR) without clinically significant macular edema (CSME), (2) NPDR with CSME, (3) proliferative diabetic retinopathy (PDR) without CSME, and (4) PDR with CSME. Variable serum metabolic markers were assessed using immunoassays. Multinomial logistic regression analysis was performed. Results. Diabetes duration and hypertension are the most significant risk factors for DR. Serum Apo-B and Apo-B/Apo-A ratio were the most significant metabolic risk factors for PDR and CSME. For every 0.1 g/L increase in Apo-B concentration, the risk of PDR and CSME increased by about 1.20 times. We also found that 10 pg/mL increase in serum TNF-α was associated with approximately 2-fold risk of PDR/CSME while an increase by 100 pg/mL in serum VEGF concentration correlated with CSME. Conclusions. In conclusion, it seems that there is a link between metabolic and inflammatory markers. Apo-B/Apo-A ratio should be evaluated as a reliable risk factor for PDR and CSME, while the role of increased systemic TNF-α and VEGF should be explored in CSME. |
format | Online Article Text |
id | pubmed-4532932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-45329322015-08-20 Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy Crosby-Nwaobi, Roxanne Chatziralli, Irini Sergentanis, Theodoros Dew, Tracy Forbes, Angus Sivaprasad, Sobha J Diabetes Res Research Article Purpose. The purpose of this study was to examine the relationship between metabolic and inflammatory markers in patients with diabetic retinopathy (DR). Methods. 208 adult patients with type 2 diabetes participated in this study and were categorized into (1) mild nonproliferative diabetic retinopathy (NPDR) without clinically significant macular edema (CSME), (2) NPDR with CSME, (3) proliferative diabetic retinopathy (PDR) without CSME, and (4) PDR with CSME. Variable serum metabolic markers were assessed using immunoassays. Multinomial logistic regression analysis was performed. Results. Diabetes duration and hypertension are the most significant risk factors for DR. Serum Apo-B and Apo-B/Apo-A ratio were the most significant metabolic risk factors for PDR and CSME. For every 0.1 g/L increase in Apo-B concentration, the risk of PDR and CSME increased by about 1.20 times. We also found that 10 pg/mL increase in serum TNF-α was associated with approximately 2-fold risk of PDR/CSME while an increase by 100 pg/mL in serum VEGF concentration correlated with CSME. Conclusions. In conclusion, it seems that there is a link between metabolic and inflammatory markers. Apo-B/Apo-A ratio should be evaluated as a reliable risk factor for PDR and CSME, while the role of increased systemic TNF-α and VEGF should be explored in CSME. Hindawi Publishing Corporation 2015 2015-07-29 /pmc/articles/PMC4532932/ /pubmed/26295054 http://dx.doi.org/10.1155/2015/191382 Text en Copyright © 2015 Roxanne Crosby-Nwaobi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Crosby-Nwaobi, Roxanne Chatziralli, Irini Sergentanis, Theodoros Dew, Tracy Forbes, Angus Sivaprasad, Sobha Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy |
title | Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy |
title_full | Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy |
title_fullStr | Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy |
title_full_unstemmed | Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy |
title_short | Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy |
title_sort | cross talk between lipid metabolism and inflammatory markers in patients with diabetic retinopathy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532932/ https://www.ncbi.nlm.nih.gov/pubmed/26295054 http://dx.doi.org/10.1155/2015/191382 |
work_keys_str_mv | AT crosbynwaobiroxanne crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy AT chatziralliirini crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy AT sergentanistheodoros crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy AT dewtracy crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy AT forbesangus crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy AT sivaprasadsobha crosstalkbetweenlipidmetabolismandinflammatorymarkersinpatientswithdiabeticretinopathy |